PIRAMAL PHARMA LIMITED — Call Transcript 2026

Apr 29, 2026

Piramal
Pharma Limited

29th April, 2026

BSE Limited
P.J. Towers, Dalal Street, Fort,
Mumbai- 400 001
BSE scrip code: 543635

National Stock Exchange of India Limited
Exchange Plaza, Bandra-Kurla Complex,
Bandra (East), Mumbai – 400 051
NSE symbol: PPLPHARMA

Sub: Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026

Dear Sir / Madam,

In continuation of our letter dated 17th April, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Conference Call held today i.e. on 29th April, 2026, on the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2026, is available on the Company’s website at https://www.piramalpharma.com/financial-reports.

Kindly take the above information on record.

Yours truly,

For Piramal Pharma Limited

VIVEK
Digitally signed
by VIVEK
VALSARAJ
Date: 2026.04.29
16:42:55 +05'30'

Vivek Valsaraj
Executive Director & Chief Financial Officer

Piramal Pharma Limited
CIN: L24297MH2020PLC338592
Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India
T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com
piramalpharma.com